Skip to main content

Blue Owl — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

68
Companies
$39.6B
Total invested
$629.1M
Avg. check
38
Industries
Biotechnology 15Health Care 11Medical 8Pharmaceutical 6Biopharma 6Therapeutics 6+32 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 68
Pyxis Oncology
September 2026

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Biotechnology · Boston$110.0M Post-IPO Equity
MapLight Therapeutics
August 2026

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Biopharma · Palo Alto$150.0M Post-IPO Equity
BridgeBio
July 2026

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Biotechnology · Palo Alto$1.0B Post-IPO Equity
Neuron23
June 2026

Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.

Health Care · San Francisco$2.5M Grant
Celcuity
June 2026

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Biotechnology · Hamel$500.0M Post-IPO Debt
Allica Bank
May 2026

Allica Bank is a fintech company that delivers digital banking services for small and medium-sized businesses.

Banking · London$20.1M Debt Financing
Windward Bio
May 2026

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

Biotechnology · Basel$165.0M Series B
ImageneBio
April 2026

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

Biopharma · San Diego$30.0M Post-IPO Equity
Ambrosia Biosciences
March 2026

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

Biopharma · Boulder$100.0M Series B
Korro Bio
March 2026

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Biotechnology · Cambridge$85.0M Post-IPO Equity
Scholar Rock
March 2026

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Biopharma · Cambridge$100.0M Post-IPO Debt
Palvella Therapeutics
February 2026

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Biotechnology · Wayne$200.0M Post-IPO Equity
Deep Fission
February 2026

Deep Fission is transforming the energy landscape by installing modular nuclear power reactors a mile deep.

Electrical Distribution · Berkeley$80.0M Undisclosed
Mirador Therapeutics
January 2026

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

Biotechnology · San Diego$250.0M Series B
Finance of America Companies
December 2025

Finance of America Companies is a consumer lending company that offers lending products and services.

Banking · New York$50.0M Post-IPO Equity
Coremont
December 2025

Coremont provides web-based portfolio management technology and outsourced services.

Finance · London$40.0M Private Equity
Clio
November 2025

Clio provides cloud-based legal practice management software, helping law firms manage cases, billing, and client relationships.

Artificial Intelligence (AI) · Vancouver$500.0M Series G
Point
November 2025

Point is a home equity platform that allows homeowners to convert a portion of their home equity into cash without taking on a loan.

Financial Services · Palo Alto$390.0M Debt Financing
Electra Therapeutics
October 2025

Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.

Biotechnology · San Francisco$183.0M Series C
TORL BioTherapeutics
October 2025

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

Biopharma · Culver City$96.0M Series C
Wrench Group
September 2025

Wrench Group offers home repair, replacement and maintenance services specializing in heating and ventilation.

Electronics · Marietta$1.3B Debt Financing
Klaviyo
August 2025

Klaviyo is an automation and email platform designed to help grow businesses.

Advertising · Boston$195.1M Post-IPO Secondary
Madrigal Pharmaceuticals
July 2025

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Biopharma · Conshohocken$350.0M Post-IPO Debt
Latigo Biotherapeutics
March 2025

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

Biotechnology · Thousand Oaks$150.0M Series B

Where Blue Owl invests

Biotechnology15
Health Care11
Medical8
Pharmaceutical6
Biopharma6
Therapeutics6

About Blue Owl's portfolio

How many companies has Blue Owl invested in?▸

Blue Owl has invested in 68 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Blue Owl invest in?▸

Blue Owl's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Biopharma. The firm invests across 38 different industry categories.

What is Blue Owl's largest investment?▸

Among tracked funding rounds, Wrench Group received $1.3B in a Debt Financing round. Blue Owl's total known invested capital is $39.6B.

What is the average investment size for Blue Owl?▸

Blue Owl's average investment size is $629.1M across its portfolio of 68 companies.

What are Blue Owl's most recent investments?▸

Recent Blue Owl portfolio additions include Pyxis Oncology, MapLight Therapeutics, BridgeBio, Neuron23, Celcuity. These companies were founded in 2020 or later.

Reach the founders behind these 68 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →